Show simple item record

dc.contributor.authorLabad, Javier
dc.contributor.authorRozadilla Sacanell, Antoni
dc.contributor.authorGarcia-Sancho, Paula
dc.contributor.authorNolla, Joan M.
dc.contributor.authorMontanya, Eduard
dc.date.accessioned2022-01-25T15:42:21Z
dc.date.available2022-01-25T15:42:21Z
dc.date.issued2018
dc.identifier.citationLabad, Javier; Rozadilla Sacanell, Antoni; Garcia-Sancho, Paula [et al.]. Limited joint mobility progression in type 1 diabetes: a 15-year follow-up study. International Journal of Endocrinology, 2018, 1897058. Disponible en: <https://www.hindawi.com/journals/ije/2018/1897058/>. Fecha de acceso: 25 ene. 2022. DOI: 10.1155/2018/1897058ca
dc.identifier.issn1687-8337ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/3098
dc.description.abstractObjective. To assess the evolution of joint mobility over a period of 15 years in type 1 diabetic patients and healthy controls and to determine whether microalbuminuria is associated with a different evolution of joint mobility. Methods. Joint mobility of hand and wrist was determined in 63 patients with type 1 diabetes and 63 healthy subjects. Fifteen years later, 37 (58.7%) diabetic patients and 16 (25.4%) healthy subjects were studied again. Joint mobility was assessed with the Prayer sign and by measuring the angle of maximal flexion of the fifth and third metacarpophalangeal (MCP) joints and wrist. Patients with diabetes were visited 2–4 times every year with regular assessment of glycated hemoglobin (HbA1c), urinary albumin excretion (UAE), and ophthalmoscopy. Results. Fifteen years after the initial exam, diabetic patients showed reduced flexion of the fifth MCP joint (82.6 ± 5.8 versus 76.0 ± 6.4 degrees, ) and wrist (75.9 ± 8.1 versus 73.2 ± 7.4 degrees, ) compared to baseline examination. Joint mobility did not change significantly in healthy subjects. Patients with microalbuminuria showed greater reduction in hand joint mobility than diabetic patients with normal UAE or than healthy subjects (). Conclusions. In type 1 diabetic patients, the severity of LJM progresses with time, and the progression is enhanced in patients with microalbuminuria.en
dc.format.extent6ca
dc.language.isoengca
dc.publisherHindawi Limitedca
dc.relation.ispartofInternational Journal of Endocrinologyca
dc.rights© 2018 Javier Labad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.otherDiabetisca
dc.subject.otherMicroalbuminúriaca
dc.subject.otherMobilitat articularca
dc.subject.otherDiabeteses
dc.subject.otherMicroalbuminuriaes
dc.subject.otherMovilidad articulares
dc.subject.otherDiabetesen
dc.subject.otherMicroalbuminuriaen
dc.subject.otherJoint mobilityen
dc.titleLimited joint mobility progression in type 1 diabetes: a 15-year follow-up studyen
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.subject.udc616.4ca
dc.identifier.doihttps://dx.doi.org/10.1155/2018/1897058ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

© 2018 Javier Labad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint